Report Highlights
The global inpatient and outpatient pharmacy automation market has grown to nearly $3.8 billion in 2016 from $3.5 billion in 2015. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.9% from 2016 to 2021, increasing to $5.5 billion in 2021.
Report Includes
- An overview of the global markets for pharmacy automation and related technologies
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
- A market breakdown of inpatient pharmacy automation into acute-care settings and long-term care settings
- A market breakdown of outpatient pharmacy automation into fast-track clinical settings, hospital retail settings, pharmacy benefit management services, and retail pharmacy chains
- A look at the impact of chronic diseases, and growing and aging populations
- Technology patent trends relating to automating processes in the pharmacy environment
- Profiles of major players in the industry
Report Scope
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the global pharmacy automation market. The geographical scope is global with special emphasis on the United States and developed Europe, with supplemental data covering other geographical markets and trends. The report identifies pharmacy automation markets by inpatient and outpatient pharmacy settings, and by product type. Within the global pharmacy automation market, there are two general pharmacy settings, each having other subsettings:
- Inpatient pharmacy automation.
- Acute-care settings.
- Long-term care settings.
- Outpatient pharmacy automation.
- Outpatient/fast-track clinical settings.
- Hospital retail settings.
- Pharmacy benefit management services and other mail-order settings.
- Retail pharmacy chains.
Each segment is further reviewed to provide detailed information of current and emerging products, current market estimates and market forecasts, and competitive analyses.
Analyst Credentials
Melissa Elder is an experienced healthcare market analyst specializing in medical treatments, equipment and devices. Ms. Elder holds an MBA in Health Care Management and provides consultation to various institutions globally. She has been involved in the healthcare industry since 1996, providing more than 23 years of industry expertise. Ms. Elder has specialized in market research for more than 20 years, focusing on the areas of advanced medical technologies, biological products and animal health. In-depth analysis into more than 100 health-related topics has given Ms. Elder substantial insight into industry dynamics, market influences and future direction of various health markets. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare specialties. She has authored several industry-specific documents and is a well-respected contributor to the market research community. Her writings are published in magazines, newspapers and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents.
Report Highlights
The global pharmacy automation market reached nearly $3.0 billion in 2012. This market is expected to grow to nearly $3.2 billion in 2013 and $4.9 billion in 2018 with a compound annual growth rate (CAGR) of 8.8% over the five-year period, 2013 to 2018
Report Includes
- An overview of the global market for pharmacy automation.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- A market breakdown of inpatient pharmacy automation into a cute-care settings and long-term care settings.
- A market breakdown of outpatient pharmacy automation into fast-track clinical settings, hospital retail settings, pharmacy benefit management services, and retail pharmacy chains
- Comprehensive profiles of leading companies in the industry.
Report Highlights
The global inpatient and outpatient pharmacy automation market was valued at $2.4 billion in 2011 and should reach $2.6 billion in 2012. Total market value is expected to reach nearly $3.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8%.
Report Highlights
-
The total worldwide market for pharmacy automation will be worth $2.2 billion by the end of 2010. The market is displaying a recovery from purchasing holds for equipment experienced by many health facilities, and is expected to grow at a 4.6% compound annual growth rate (CAGR) to reach $2.7 billion in 2015.
-
Inpatient pharmacy automation revenues account for the larger share of the market, with sales expected to reach $1.7 billion by the end of 2010 and increase by a 5.2% compound annual growth rate (CAGR) to reach $2.2 billion by 2015.
-
Outpatient pharmacy automation revenues are estimated at $456 million for 2010. By 2015, the outpatient pharmacy automation market is expected to reach $510 million in revenues after increasing at a compound annual growth rate (CAGR) of 2.3%.
Report Highlights
- The global market for pharmacy automation increased from $2.1 billion in 2006 to $2.3 billion in 2007. It should reach $3.6 billion by 2012, a compound annual growth rate (CAGR) of 9.4%.
- By 2012, the inpatient pharmacy automation market is expected to be worth nearly $2.9 billion, a CAGR of 9.8%.
- The outpatient pharmacy automation segment will continue to experience moderate growth through 2012, with a CAGR of 7.8% over the next 5 years.
Related Reports
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
Latin America Retail Industry Profile and Directory
Latin American (LATAM) retail market will grow from $263.4 billion in 2017 to nearly $297.9 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
Anesthesia and Respiratory Devices: Global Markets
Find an in-depth analysis of the global market for anesthetic and respiratory devices, including market estimations and trends through 2020.
Recent Reports
Microscopy: The Global Market
The global market for microscopy is expected to grow from $9.7 billion in 2024 and is projected to reach $13.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2024 to 2029.
Environmental Sensing and Monitoring Technologies: Global Markets
The global market for environmental sensing and monitoring technologies is estimated to increase from 31.3 billion in 2024 to reach $41.4 billion by 2029, at a compound annual growth rate (CAGR) of 5.7% from 2024 through 2029.
Protective Relays and Circuit Breakers: Global Markets
The global market for protective relays and circuit breakers was valued at $16.9 billion in 2023. This market is expected to grow from $17.2 billion in 2024 to $26.8 billion by 2029, at a compound annual growth rate (CAGR) of 9.2% from 2024 through 2029.
Brain-Computer Interface: Global Markets
The global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029, at a compound annual growth rate (CAGR) of 14.2% from 2024 through 2029.
Educational Equipment and Software: Global Markets
The global market for educational equipment and software is expected to grow from $105.4 billion in 2024 and is projected to reach $187.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.2% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More